M. B. Wallace

发表

Structure-based design and synthesis of pyrrole derivatives as MEK inhibitors.

C. Mol, V. Feher, Lihong Shi, 2010, Bioorganic & medicinal chemistry letters.

Design and synthesis of orally available MEK inhibitors with potent in vivo antitumor efficacy.

Lihong Shi, L. Zhang, Petro Halkowycz, 2012, Bioorganic & medicinal chemistry letters.

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies.

D. Matthews, R. Babine, S. Webber, 1998, Journal of medicinal chemistry.

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies.

D. Matthews, R. Babine, S. Webber, 1998, Journal of medicinal chemistry.

Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV.

D. Kassel, S. L. Gwaltney, K. Aertgeerts, 2011, Journal of medicinal chemistry.

Discovery of TAK-733, a potent and selective MEK allosteric site inhibitor for the treatment of cancer.

Lihong Shi, Petro Halkowycz, D. Dougan, 2011, Bioorganic & medicinal chemistry letters.

Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors.

D. Kassel, S. L. Gwaltney, Lihong Shi, 2008, Bioorganic & medicinal chemistry letters.

KDM4 Inhibition Targets Breast Cancer Stem-like Cells.

Nicola Iovino, M. Boerries, E. Stickeler, 2017, Cancer research.

The Influence of Hapten Size and Hydrophobicity on the Catalytic Activity of Elicited Polyclonal Antibodies

B. Iverson, M. B. Wallace, 1996 .

Intramolecular Diels–Alder synthesis of 7-aza-α-carboline compounds

J. Stafford, N. Scorah, Dong Qing, 2010 .

Intramolecular Diels—Alder Synthesis of 7-Aza-α-carboline Compounds.

J. Stafford, N. Scorah, Dong Qing, 2010 .

Evolution of Catalytic Activity throughout a Polyclonal Immune Response Elicited by a Transition‐State‐Analog Hapten

B. Iverson, E. Helms, K. Shreder, 1996 .

Advanced Imaging Techniques and In vivo Histology: Current Status and Future Perspectives (Lower G.I.)

Pujan Kandel, M. B. Wallace, 2021, Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy.

Design of KDM4 Inhibitors with Antiproliferative Effects in Cancer Models.

J. Veal, T. Bonaldi, D. Hosfield, 2017, ACS medicinal chemistry letters.

Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV.

D. Kassel, S. L. Gwaltney, K. Takeuchi, 2007, Journal of medicinal chemistry.

Synthetic approaches to 1,8-naphthyridine-2,5-dione compounds

M. Wallace, Toufike Kanouni, Dong Qing, 2011 .

Substituted benzamide inhibitors of human rhinovirus 3C protease: structure-based design, synthesis, and biological evaluation.

D. Matthews, T. Hendrickson, R. Ferre, 2000, Journal of medicinal chemistry.

Design and synthesis of orally available MEK inhibitors with potent in vivo antitumor efficacy.

Lihong Shi, L. Zhang, Petro Halkowycz, 2012, Bioorganic & medicinal chemistry letters.